The benefits of combining industry, academia and research to develop drugs: Doctors not only have professional knowledge, but also can contact patients in actual work, which is of great help to the iterative innovation of medical equipment and technology for enterprises.
Innovation is more than just writing an article. If China does not have independently developed products, it can only be called a big country, but not a powerful country. Therefore, it must concentrate its efforts on solving the problem of foreign technology being stuck. Doctors are indirect consumers of drugs. They can rely on existing clinical, R&D and talent resources and take the joint construction of hospitals and enterprises as an opportunity to explore new models of scientific and technological innovation, cooperation and transformation, and promote the innovation and transformation of clinical medicine and social resources and medical and health care. The market is closely integrated and organically integrated to create a new ecology of 'industry-university-research' virtuous cycle.
The new joint intraarticular injection jointly developed by Bloomage Biotech and Peking Union Medical College Hospital uses the nanomaterial sustained-release technology previously developed by the team to prepare joint intraarticular injection with high loading and good sustained release capabilities. The sustained-release solution is expected to have strong analgesic and chondroprotective effects. A single injection of the sustained-release solution can achieve long-term pain relief, and has very broad clinical application prospects.
If you want to know more about medical issues, it is recommended to consult Bloomage Biotech.